Uptravi 1600MCG tablet

Ended Awarded Last action

Contract number
36C26021F0041
Awardee
Awarding agency
Obligated
$171,510

Award facts

Contract value 100% obligated
$171,510.26 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
South San Francisco, CA 94080, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 $27,151
Original award $144,359

About this award

This federal contract award, valued at $171,510.26, was issued by the Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer. The award is a Blanket Purchase Agreement (BPA) call order under Actelion's existing $105 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract is for the supply of UPTRAVI 1600MCG TABLET, a medication used to treat pulmonary arterial hypertension. This award is not subject to any small business set-aside requirements. Actelion is a large pharmaceutical company that provides a range of specialized drug therapies to federal agencies, primarily the VA and Federal Bureau of Prisons, through its FSS and BPA contract vehicles. The company has also been awarded a separate $60 million BPA specifically for pulmonary arterial hypertension therapies, as well as a new $83.5 million single-award BPA covering several of Actelion's critical medications.

Quick answers

Who was awarded contract 36C26021F0041?

36C26021F0041 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2020.

How much is contract 36C26021F0041 worth?

The government has obligated $171,510 on 36C26021F0041.

Is contract 36C26021F0041 an order under another contract?

Yes. 36C26021F0041 is a BPA call under 36F79719D0142-36E79719A0019, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26021F0041 competed?

The extent of competition for 36C26021F0041 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award